BriaCell adds Memorial Sloan Kettering to Phase 3 breast cancer trial
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL; TSX: BCT) announced that Memorial Sloan Kettering Cancer Center (MSK) has joined its ongoing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
